Helmerich and Payne Inc
F:HPC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Helmerich and Payne Inc
F:HPC
|
US |
|
E
|
Esperion Therapeutics Inc
F:0ET
|
US |
|
B
|
Barclays PLC
F:BCY
|
UK |
Wall St Price Targets
HPC Price Targets Summary
Helmerich and Payne Inc
According to Wall Street analysts, the average 1-year price target for HPC is 32.51 EUR with a low forecast of 25.41 EUR and a high forecast of 38.75 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HPC's stock price target?
Price Target
32.51
EUR
According to Wall Street analysts, the average 1-year price target for HPC is 32.51 EUR with a low forecast of 25.41 EUR and a high forecast of 38.75 EUR.
What is the Revenue forecast for Helmerich and Payne Inc?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 5 years is 2%.
What is the Operating Income forecast for Helmerich and Payne Inc?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Operating Income has been -10%. The projected CAGR for the next 3 years is 13%.
